|
1.
|
Hamburger AW and Salmon SE: Primary
bioassay of human tumor stem cells. Science. 197:461–463. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Huntly BJP and Gilliland DG: Leukaemia
stem cells and the evolution of cancer-stem-cell research. Nat Rev
Cancer. 5:311–321. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ross RA and Spengler BA: Human
neuroblastoma stem cells. Semin Cancer Biol. 17:241–247. 2007.
View Article : Google Scholar
|
|
5.
|
Bilir A, Erguven M, Yazihan N, Aktas E,
Oktem G and Sabanci A: Enhancement of vinorelbine-induced
cytotoxicity and apoptosis by clomipramine and lithium chloride in
human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol.
100:385–395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Abbott BL: ABCG2 (BCRP): a cytoprotectant
in normal and malignant stem cells. Clin Adv Hematol Oncol.
4:63–72. 2006.PubMed/NCBI
|
|
7.
|
Nan JN, Hu XG and Li HX: Research progress
in tumor stem cells: literature retrieval results based on
international database. Chin J Tiss Eng Res. 516:1085–1093.
2012.
|
|
8.
|
Huang SM, Mishina YM, Liu S, et al:
Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling.
Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Chen B, Dodge ME, Tang W, et al: Small
molecule-mediated disruption of Wnt-dependent signaling in tissue
regeneration and cancer. Nat Chem Biol. 5:100–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Xu D, Zheng C, Bergenbrant S, Holm G,
Björkholm M, Yi Q and Gruber A: Telomerase activity in plasma cell
dyscrasias. Br J Cancer. 84:621–625. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
MacNamara B, Wang W, Chen Z, et al:
Telomerase activity in relation to pro- and anti-apoptotic protein
expression in high grade non-Hodgkin’s lymphomas. Haematologica.
86:386–393. 2001.PubMed/NCBI
|
|
12.
|
Klapper W, Krams M, Qian W, Janssen D and
Parwaresch R: Telomerase activity in B-cell non-Hodgkin lymphomas
is regulated by hTERT transcription and correlated with
telomere-binding protein expression but uncoupled from
proliferation. Br J Cancer. 89:713–719. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gelmini S, Poggesi M, Distante V, et al:
Tankyrase, a positive regulator of telomere elongation, is over
expressed in human breast cancer. Cancer Lett. 216:81–87. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gelmini S, Poggesi M, Pinzani P, et al:
Distribution of tankyrase-1 mRNA expression in colon cancer and its
prospective correlation with progression stage. Oncol Rep.
16:1261–1266. 2006.
|
|
15.
|
Gelmini S, Quattrone S, Malentacchi F, et
al: Tankyrase-1 mRNA expression in bladder cancer and paired urine
sediment: preliminary experience. Clin Chem Lab Med. 45:862–866.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shervington A, Patel R, Lu C, et al:
Telomerase subunits expression variation between biopsy samples and
cell lines derived from malignant glioma. Brain Res. 1134:45–52.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tian XH, Hou WJ, Fang Y, et al: XAV939, a
tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma
cell lines by inhibiting Wnt/β-catenin signaling pathway. J Exp
Clin Cancer Res. 32:100–109. 2013.PubMed/NCBI
|
|
18.
|
Vangipuram SD, Buck SA and Lyman WD: Wnt
pathway activity confers chemoresistance to cancer stem-like cells
in a neuroblastoma cell line. Tumour Biol. 33:2173–2183. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Al-Hajj M and Clarke MF: Self renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
21.
|
Lou H and Dean M: Targeted therapy for
cancer stem cells: the patched pathway and ABC transporters.
Oncogene. 26:1357–1360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
27.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
29.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumor initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mahller YY, Williams JP, Baird WH, et al:
Neuroblastoma cell lines contain pluripotent tumor initiating cells
that are susceptible to a targeted oncolytic virus. PLoS One.
4:e42352009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Hemmati HD, Nakano I, Lazareff JA, et al:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Na YR, Seok SH, Kim DJ, et al: Isolation
and characterization of spheroid cells from human malignannt
melanoma cell line WM-266-4. Tumor Biol. 30:300–309. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Di Fiore R, Santulli A, Ferrante RD, et
al: Identification and expansion of human osteosarcoma-cancer-stem
cells by long-term 3-aminobenzamide treatment. J Cell Physiol.
219:301–313. 2009.PubMed/NCBI
|
|
34.
|
Das B, Tsuchida R, Malkin D, Koren G,
Baruchel S and Yeger H: Hypoxia enhances tumor stemness by
increasing the invasive and tumorigenic side population fraction.
Stem Cells. 26:1818–1830. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Marzi I, D’Amico M, Biagiotti T, et al:
Purging of the neuroblastoma stem cell compartment and tumor
regression on exposure to hypoxia or cytotoxic treatment. Cancer
Res. 67:2402–2407. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Deng YW, Fang JS, Li MC, et al:
Correlation research between cancer stem cells and the pathological
grades of neuroepithelial tumors. J Cent South Uniu (Med Sci).
31:45–51. 2006.PubMed/NCBI
|
|
37.
|
Abbott A: Cancer: the root of the problem.
Nature. 442:742–743. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Lindvall C, Bu W, Williams BO and Li Y:
Wnt signaling, stem cells, and the cellular origin of breast
cancer. Stem Cell Rev. 3:157–168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Fu JK, Wang Z and Wei S: Alterations and
its mechanisms of Wnt signal pathway in human high-matastatatic
large cell lung cancer cell line L9981 by transfecting with Nm23-H1
gene. Chin J Lung Cancer. 12:477–479. 2009.
|
|
40.
|
Nguyen DX, Chiang AC, Zhang XH, et al:
WNT/TCF signaling through LEF1 and HOXB9 mediates lung
adenocarcinoma metastasis. Cell. 138:51–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Akiri G, Cherian MM, Vijayakumar S, Liu G,
Bafico A and Aaronson SA: Wnt pathway aberrations including
autocrine Wnt activation occur at high frequency in human
non-small-cell lung carcinoma. Oncogene. 28:2163–2172. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Sun JZ, Yang XX, Hu NY, Li X, Li FX and Li
M: Genetic variants in MMP9 and TGF2 contribute to susceptibility
to lung cancer. Chin J Cancer. 23:183–187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Kim J, You L, Xu Z, et al: Wnt inhibitory
factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg.
133:733–737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Katoh Y and Katoh M: Comparative genomics
on PROM1 gene encoding stem cell marker CD133. Int J Mol Med.
19:967–970. 2007.PubMed/NCBI
|
|
45.
|
Horst D, Kriegl L, Engel J, Jung A and
Kirchner T: CD133 and nuclear beta-catenin: the marker combination
to detect high risk cases of low stage colorectal cancer. Eur J
Cancer. 45:2034–2040. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Ruck P, Xiao JC, Pietsch T, Von Schweinitz
D and Kaiserling E: Hepatic stem-like cells in hepatoblastoma:
expression of cytokeratin 7, albumin and oval cell associated
antigens detected by OV-1 and OV-6. Histopathology. 31:324–329.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Karner CM, Merkel CE, Dodge M, Ma Z, Lu J,
Chen C, Lum L and Carroll TJ: Tankyrase is necessary for canonical
Wnt signaling during kidney development. Dev Dyn. 239:2014–2023.
2010. View Article : Google Scholar
|
|
48.
|
Chung SS, Giehl N, Wu Y and Vadgama JV:
STAT3 activation in HER2-overexpressing breast cancer promotes
epithelialmesenchymal transition and cancer stem cell traits. Int J
Oncol. 44:403–411. 2014.PubMed/NCBI
|
